Inactive 8(a) Sole Source (FAR 19.8)

The Food and Drug Administration (FDA) has a requirement under Request for Quotes: FDA-SS-RFQ-2020-1233532 to procure a PhysioMimix CN Bio Organ Chip Equipment System, plus four (4) option years (12 M... The Food and Drug Administration (FDA) has a requirement under Request for Quotes: FDA-SS-RFQ-2020-1233532 to procure a PhysioMimix CN Bio Organ Chip Equipment System, plus four (4) option years (12 Months) of Preventative Maintenance Agreement (PMA) as a sole source acquisition.